Therefore, our data are consistent with an emerging theme with respect to xCT-mediated tumor cell survival, and sets the stage for derivative studies aimed at determining whether targeting the xCT/OSGIN1 axis will also impact proteins involved in the PEL cell cycle. Here, SLC7A11 is linked to neoplasm.